ResearcherFirst Affiliated Hospital of Henan University of Science and TechnologyNo recent work listed

Shegan Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0449-2909; OpenAlex author ID A5101731416. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 2 papers

Papers 2

Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. First author DOI 10.1007/s12013-014-0345-2 ↗
The advances of Midkine with peripheral invasion in pancreatic cancer. Last author PMID 26609495 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Yao · 1 shared paper, 2015 · strength 0.08
- Paper The advances of Midkine with peripheral invasion in pancreatic cancer. PMID 26609495 ↗
Xiaoshan Feng · 1 shared paper, 2015 · strength 0.05
- Paper Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Ca… DOI 10.1007/s12013-014-0345-2 ↗
Ye Chen · 1 shared paper, 2015 · strength 0.05
- Paper Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Ca… DOI 10.1007/s12013-014-0345-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.